Brief: Ryvu Theraputics Q2 Net Loss At 30.4 Mln Zlotys
Sept 11 (Reuters) - Ryvu Theraputics SA RVU.WA :
* SAID ON WEDNESDAY Q2 NET LOSS 30.4 MLN ZLOTYS
* Q2 REVENUE 15.7 MLN ZLOTYS
* Q2 OPERATING LOSS 32.8 MLN ZLOTYS
Source text for Workspace: urn:newsml:reuters.com:*:nEM34KKQba
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys